Document is current
Any future updates will be listed below
-
Authors
Forte, Dorian https://orcid.org/0000-0002-8443-605X
Pellegrino, Roberto Maria https://orcid.org/0000-0001-5594-383X
Falvo, Paolo https://orcid.org/0000-0001-5743-5046
Garcia-Gonzalez, Paulina
Alabed, Husam B. R.
Maltoni, Filippo
Lombardi, Davide
Bruno, Samantha https://orcid.org/0000-0001-6375-0595
Barone, Martina https://orcid.org/0000-0003-3356-9861
Pasini, Federico https://orcid.org/0009-0000-1719-1585
Fabbri, Francesco
Vannini, Ivan
Donati, Benedetta
Cristiano, Gianluca
Sartor, Chiara
Ronzoni, Simona
Ciarrocchi, Alessia https://orcid.org/0000-0002-5541-2075
Buratta, Sandra
Urbanelli, Lorena https://orcid.org/0000-0003-0621-8476
Emiliani, Carla
Soverini, Simona
Catani, Lucia
Bertolini, Francesco https://orcid.org/0000-0001-5660-3255
Argüello, Rafael José https://orcid.org/0000-0001-9785-3883
Cavo, Michele
Curti, Antonio https://orcid.org/0000-0002-7752-6049
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (20654)
Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (RC-2023-2778890)
- License Information
-
More Information
Article History
Received: 1 October 2023
Accepted: 3 December 2024
First Online: 30 December 2024
Competing interests
: The authors declare no competing interests.
: The research was approved by the institutional review board of the Area Vasta Emilia Centro (AVEC) Ethical Committee (approval code: 94/2016/O/Tess).
